STOCK TITAN

[Form 4] ARKO Corp. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

On 30 June 2025 and 1 July 2025, ReposiTrak Inc. (TRAK) Chairman, CEO and >10 % owner Randall K. Fields reported the sale of a combined 7,500 common shares under a pre-arranged Rule 10b5-1 trading plan executed through RK Fields Charitable 2022, LLC. Weighted-average prices were $20.0089 and $19.4508, reflecting intraday ranges of $19.785–$20.10 and $19.215–$19.66, respectively.

Post-transaction, Fields continues to own approximately 3.68 million shares directly and over 1.14 million shares indirectly (including common and Series B preferred stock), maintaining a substantial insider position. The divestiture represents <0.2 % of his total common-stock holdings; therefore, it does not materially alter his voting power or economic exposure.

No derivative transactions were reported, and the filing cites charitable commitments as the rationale for the sales. Given the small proportion sold, the automatic nature of the plan, and the continued large stake, the disclosure is viewed as routine with limited near-term impact on the company’s valuation or governance dynamics.

Il 30 giugno 2025 e il 1° luglio 2025, Randall K. Fields, Presidente, CEO e azionista con oltre il 10% di ReposiTrak Inc. (TRAK), ha comunicato la vendita complessiva di 7.500 azioni ordinarie nell'ambito di un piano di trading predefinito ai sensi della Regola 10b5-1, eseguito tramite RK Fields Charitable 2022, LLC. I prezzi medi ponderati sono stati di 20,0089 $ e 19,4508 $, con intervalli intraday rispettivamente di 19,785–20,10 $ e 19,215–19,66 $.

Dopo la transazione, Fields detiene ancora circa 3,68 milioni di azioni direttamente e oltre 1,14 milioni di azioni indirettamente (inclusi azioni ordinarie e azioni privilegiate di Serie B), mantenendo una posizione interna significativa. La cessione rappresenta meno dello 0,2% del totale delle sue azioni ordinarie; pertanto, non modifica sostanzialmente il suo potere di voto né l'esposizione economica.

Non sono state segnalate transazioni derivati e la comunicazione indica impegni di beneficenza come motivo delle vendite. Considerando la piccola quota venduta, la natura automatica del piano e la consistente partecipazione residua, la divulgazione è considerata di routine con un impatto limitato a breve termine sulla valutazione o sulla governance dell'azienda.

El 30 de junio y el 1 de julio de 2025, Randall K. Fields, presidente, CEO y propietario de más del 10% de ReposiTrak Inc. (TRAK), informó la venta conjunta de 7,500 acciones comunes bajo un plan de negociación preestablecido conforme a la Regla 10b5-1, ejecutado a través de RK Fields Charitable 2022, LLC. Los precios promedio ponderados fueron de $20.0089 y $19.4508, con rangos intradía de $19.785–$20.10 y $19.215–$19.66, respectivamente.

Tras la transacción, Fields continúa poseyendo aproximadamente 3.68 millones de acciones directamente y más de 1.14 millones de acciones indirectamente (incluyendo acciones comunes y preferentes Serie B), manteniendo una posición interna significativa. La venta representa menos del 0.2% de su total de acciones comunes; por lo tanto, no altera materialmente su poder de voto ni su exposición económica.

No se reportaron transacciones derivadas, y el informe cita compromisos benéficos como motivo de las ventas. Dada la pequeña proporción vendida, la naturaleza automática del plan y la considerable participación mantenida, la divulgación se considera rutinaria con un impacto limitado a corto plazo en la valoración o dinámica de gobernanza de la empresa.

2025년 6월 30일과 7월 1일에 ReposiTrak Inc.(TRAK)의 회장 겸 CEO이자 10% 이상 지분 보유자인 Randall K. Fields가 RK Fields Charitable 2022, LLC를 통해 실행된 Rule 10b5-1 거래 계획에 따라 총 7,500주 보통주를 매각했다고 보고했습니다. 가중평균 가격은 각각 $20.0089$19.4508였으며, 일중 가격 범위는 각각 $19.785–$20.10 및 $19.215–$19.66였습니다.

거래 후 Fields는 약 368만 주를 직접 보유하고, 114만 주 이상을 간접 보유하고 있으며(보통주 및 시리즈 B 우선주 포함) 중요한 내부자 지분을 유지하고 있습니다. 이번 매각은 그의 총 보통주 보유량의 0.2% 미만에 해당하며, 따라서 그의 의결권이나 경제적 노출에 실질적인 변화를 주지 않습니다.

파생상품 거래는 보고되지 않았으며, 매각 사유로는 자선 기부 약속이 언급되었습니다. 매각 비율이 적고 계획이 자동으로 이루어졌으며 여전히 큰 지분을 보유하고 있어 이번 공시는 회사 가치 평가나 거버넌스에 단기적으로 큰 영향을 미치지 않는 일상적인 보고로 간주됩니다.

Les 30 juin et 1er juillet 2025, Randall K. Fields, président, PDG et détenteur de plus de 10 % de ReposiTrak Inc. (TRAK), a déclaré la vente conjointe de 7 500 actions ordinaires dans le cadre d’un plan de négociation préétabli conforme à la règle 10b5-1, exécuté via RK Fields Charitable 2022, LLC. Les prix moyens pondérés étaient de 20,0089 $ et 19,4508 $, avec des fourchettes intrajournalières respectives de 19,785–20,10 $ et 19,215–19,66 $.

Après la transaction, Fields détient toujours environ 3,68 millions d’actions en direct et plus de 1,14 million d’actions indirectement (y compris des actions ordinaires et des actions privilégiées de série B), conservant une position d’initié importante. La cession représente moins de 0,2 % de son total d’actions ordinaires ; elle n’altère donc pas de manière significative son pouvoir de vote ni son exposition économique.

Aucune transaction dérivée n’a été signalée, et le dépôt mentionne des engagements caritatifs comme raison des ventes. Étant donné la faible proportion vendue, la nature automatique du plan et la participation importante maintenue, cette divulgation est considérée comme routinière avec un impact limité à court terme sur la valorisation ou la gouvernance de l’entreprise.

Am 30. Juni und 1. Juli 2025 meldete Randall K. Fields, Vorsitzender, CEO und Eigentümer von mehr als 10 % von ReposiTrak Inc. (TRAK), den Verkauf von insgesamt 7.500 Stammaktien im Rahmen eines vorab vereinbarten Rule 10b5-1 Handelsplans, der über RK Fields Charitable 2022, LLC ausgeführt wurde. Die gewichteten Durchschnittspreise lagen bei 20,0089 $ und 19,4508 $ mit Intraday-Spannen von 19,785–20,10 $ bzw. 19,215–19,66 $.

Nach der Transaktion hält Fields weiterhin etwa 3,68 Millionen Aktien direkt und über 1,14 Millionen Aktien indirekt (einschließlich Stammaktien und Vorzugsaktien der Serie B) und behält damit eine bedeutende Insiderposition. Der Verkauf entspricht weniger als 0,2 % seines gesamten Stammaktienbestands und verändert daher weder seine Stimmrechte noch seine wirtschaftliche Beteiligung wesentlich.

Es wurden keine Derivatgeschäfte gemeldet, und als Grund für die Verkäufe werden wohltätige Verpflichtungen angegeben. Aufgrund des geringen Anteils, der automatischen Natur des Plans und des weiterhin großen Anteils wird die Offenlegung als Routine angesehen, mit begrenzten kurzfristigen Auswirkungen auf die Unternehmensbewertung oder Governance-Dynamik.

Positive
  • Insider retains a substantial stake (>4.8 million combined shares), signalling continued alignment with shareholders.
  • Sales executed via a pre-established Rule 10b5-1 plan for charitable purposes, reducing concerns about information asymmetry.
Negative
  • Any insider selling by the CEO can be perceived as a bearish signal despite limited size.
  • No offsetting insider purchases were disclosed, offering little immediate bullish sentiment.

Insights

TL;DR: Small, pre-planned insider sale; minimal impact on ownership or outlook.

The combined 7,500-share sale equates to roughly 0.17 % of Fields’ 4.4 million total common shares. Executed under a 10b5-1 plan and earmarked for charitable funding, the transaction lacks adverse informational signaling. Fields’ >10 % stake and CEO role remain intact, preserving alignment with shareholders. Volume is immaterial relative to the average daily trading volume, suggesting negligible market pressure. Overall, I classify the filing as neutral for valuation purposes.

TL;DR: Governance risk unchanged; sale is compliant and transparent.

The use of a disclosed 10b5-1 plan and charitable purpose limits perception of opportunistic timing. Compliance with SEC disclosure timelines appears intact, and Fields maintains a dominant equity position, preserving strategic continuity. No red flags emerge regarding insider information misuse or shifting control. Consequently, the impact on governance quality and investor confidence is neutral.

Il 30 giugno 2025 e il 1° luglio 2025, Randall K. Fields, Presidente, CEO e azionista con oltre il 10% di ReposiTrak Inc. (TRAK), ha comunicato la vendita complessiva di 7.500 azioni ordinarie nell'ambito di un piano di trading predefinito ai sensi della Regola 10b5-1, eseguito tramite RK Fields Charitable 2022, LLC. I prezzi medi ponderati sono stati di 20,0089 $ e 19,4508 $, con intervalli intraday rispettivamente di 19,785–20,10 $ e 19,215–19,66 $.

Dopo la transazione, Fields detiene ancora circa 3,68 milioni di azioni direttamente e oltre 1,14 milioni di azioni indirettamente (inclusi azioni ordinarie e azioni privilegiate di Serie B), mantenendo una posizione interna significativa. La cessione rappresenta meno dello 0,2% del totale delle sue azioni ordinarie; pertanto, non modifica sostanzialmente il suo potere di voto né l'esposizione economica.

Non sono state segnalate transazioni derivati e la comunicazione indica impegni di beneficenza come motivo delle vendite. Considerando la piccola quota venduta, la natura automatica del piano e la consistente partecipazione residua, la divulgazione è considerata di routine con un impatto limitato a breve termine sulla valutazione o sulla governance dell'azienda.

El 30 de junio y el 1 de julio de 2025, Randall K. Fields, presidente, CEO y propietario de más del 10% de ReposiTrak Inc. (TRAK), informó la venta conjunta de 7,500 acciones comunes bajo un plan de negociación preestablecido conforme a la Regla 10b5-1, ejecutado a través de RK Fields Charitable 2022, LLC. Los precios promedio ponderados fueron de $20.0089 y $19.4508, con rangos intradía de $19.785–$20.10 y $19.215–$19.66, respectivamente.

Tras la transacción, Fields continúa poseyendo aproximadamente 3.68 millones de acciones directamente y más de 1.14 millones de acciones indirectamente (incluyendo acciones comunes y preferentes Serie B), manteniendo una posición interna significativa. La venta representa menos del 0.2% de su total de acciones comunes; por lo tanto, no altera materialmente su poder de voto ni su exposición económica.

No se reportaron transacciones derivadas, y el informe cita compromisos benéficos como motivo de las ventas. Dada la pequeña proporción vendida, la naturaleza automática del plan y la considerable participación mantenida, la divulgación se considera rutinaria con un impacto limitado a corto plazo en la valoración o dinámica de gobernanza de la empresa.

2025년 6월 30일과 7월 1일에 ReposiTrak Inc.(TRAK)의 회장 겸 CEO이자 10% 이상 지분 보유자인 Randall K. Fields가 RK Fields Charitable 2022, LLC를 통해 실행된 Rule 10b5-1 거래 계획에 따라 총 7,500주 보통주를 매각했다고 보고했습니다. 가중평균 가격은 각각 $20.0089$19.4508였으며, 일중 가격 범위는 각각 $19.785–$20.10 및 $19.215–$19.66였습니다.

거래 후 Fields는 약 368만 주를 직접 보유하고, 114만 주 이상을 간접 보유하고 있으며(보통주 및 시리즈 B 우선주 포함) 중요한 내부자 지분을 유지하고 있습니다. 이번 매각은 그의 총 보통주 보유량의 0.2% 미만에 해당하며, 따라서 그의 의결권이나 경제적 노출에 실질적인 변화를 주지 않습니다.

파생상품 거래는 보고되지 않았으며, 매각 사유로는 자선 기부 약속이 언급되었습니다. 매각 비율이 적고 계획이 자동으로 이루어졌으며 여전히 큰 지분을 보유하고 있어 이번 공시는 회사 가치 평가나 거버넌스에 단기적으로 큰 영향을 미치지 않는 일상적인 보고로 간주됩니다.

Les 30 juin et 1er juillet 2025, Randall K. Fields, président, PDG et détenteur de plus de 10 % de ReposiTrak Inc. (TRAK), a déclaré la vente conjointe de 7 500 actions ordinaires dans le cadre d’un plan de négociation préétabli conforme à la règle 10b5-1, exécuté via RK Fields Charitable 2022, LLC. Les prix moyens pondérés étaient de 20,0089 $ et 19,4508 $, avec des fourchettes intrajournalières respectives de 19,785–20,10 $ et 19,215–19,66 $.

Après la transaction, Fields détient toujours environ 3,68 millions d’actions en direct et plus de 1,14 million d’actions indirectement (y compris des actions ordinaires et des actions privilégiées de série B), conservant une position d’initié importante. La cession représente moins de 0,2 % de son total d’actions ordinaires ; elle n’altère donc pas de manière significative son pouvoir de vote ni son exposition économique.

Aucune transaction dérivée n’a été signalée, et le dépôt mentionne des engagements caritatifs comme raison des ventes. Étant donné la faible proportion vendue, la nature automatique du plan et la participation importante maintenue, cette divulgation est considérée comme routinière avec un impact limité à court terme sur la valorisation ou la gouvernance de l’entreprise.

Am 30. Juni und 1. Juli 2025 meldete Randall K. Fields, Vorsitzender, CEO und Eigentümer von mehr als 10 % von ReposiTrak Inc. (TRAK), den Verkauf von insgesamt 7.500 Stammaktien im Rahmen eines vorab vereinbarten Rule 10b5-1 Handelsplans, der über RK Fields Charitable 2022, LLC ausgeführt wurde. Die gewichteten Durchschnittspreise lagen bei 20,0089 $ und 19,4508 $ mit Intraday-Spannen von 19,785–20,10 $ bzw. 19,215–19,66 $.

Nach der Transaktion hält Fields weiterhin etwa 3,68 Millionen Aktien direkt und über 1,14 Millionen Aktien indirekt (einschließlich Stammaktien und Vorzugsaktien der Serie B) und behält damit eine bedeutende Insiderposition. Der Verkauf entspricht weniger als 0,2 % seines gesamten Stammaktienbestands und verändert daher weder seine Stimmrechte noch seine wirtschaftliche Beteiligung wesentlich.

Es wurden keine Derivatgeschäfte gemeldet, und als Grund für die Verkäufe werden wohltätige Verpflichtungen angegeben. Aufgrund des geringen Anteils, der automatischen Natur des Plans und des weiterhin großen Anteils wird die Offenlegung als Routine angesehen, mit begrenzten kurzfristigen Auswirkungen auf die Unternehmensbewertung oder Governance-Dynamik.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Edmiston Sherman III

(Last) (First) (Middle)
8565 MAGELLAN PARKWAY
SUITE 400

(Street)
RICHMOND VA 23227

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ARKO Corp. [ ARKO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
07/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (1) 07/01/2025 A 542 (2) (2) Common Stock, par value $0.0001 per share 542 $0 97,273 D
Explanation of Responses:
1. Restricted stock units ("RSUs") provide for the right to receive one share of common stock, $0.0001 par value per share ("common stock"), of ARKO Corp. (the "Company") on a one-for-one basis.
2. The RSUs are immediately vested and provide for the right to receive one share of common stock upon the earlier of (i) the date on which the reporting person's service with the Company is terminated (for whatever reason) and (ii) the date of a change of control of the Company.
/s/ Maury Bricks, Attorney-in-Fact 07/02/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many ReposiTrak (TRAK) shares did CEO Randall Fields sell?

7,500 common shares—2,626 on 30 June 2025 and 4,874 on 1 July 2025.

At what prices were the TRAK shares sold?

Weighted averages of $20.0089 (range $19.785–$20.10) and $19.4508 (range $19.215–$19.66).

Why were the shares sold?

The transactions were automatic under a Rule 10b5-1 plan to meet the reporting person’s charitable commitments.

How many TRAK shares does Randall Fields still own?

Approximately 3.68 million shares directly and about 1.14 million shares indirectly after the sales.

Does the sale affect Fields’ status as a >10 % owner?

No. His holdings remain well above the 10 % threshold, so he continues to be a >10 % beneficial owner.
Arko

NASDAQ:ARKO

ARKO Rankings

ARKO Latest News

ARKO Latest SEC Filings

ARKO Stock Data

528.75M
72.93M
29.96%
62.83%
2.14%
Specialty Retail
Retail-convenience Stores
Link
United States
RICHMOND